XML 51 R29.htm IDEA: XBRL DOCUMENT

Equity Method Accounting for Common Stock of Asterias, at Fair Value (Tables)

12 Months Ended

Dec. 31, 2017

Asterias Biotherapeutics [Member]

Schedule of Equity Method Investments [Line Items]

Schedule of Condensed Results of Operations and Condensed Balance Sheet Information

The condensed results of operations and condensed balance sheet information of Asterias are summarized below (in thousands):

		For the Period January 1, 2016 through May 12, 2016 ⁽¹⁾
Condensed Statement of Operations ⁽¹⁾:
Total revenue		$	2,354
Gross profit			2,301
Loss from operations			(13,944)
Net loss		$	(13,113)

(1)

Asterias condensed results of operations for the period from January 1, 2016 through May 12, 2016, the date immediately preceding the Asterias Deconsolidation, for the year ended December 31, 2016, and for the year ended December 31, 2015, shown in the table below, are included in the consolidated results of operations of BioTime for the years ended December 31, 2016 and 2015, respectively, after intercompany eliminations, as applicable.

The following table summarizes Asterias results of operations for the full years ended December 31, 2017, 2016 and 2015 (in thousands).

Condensed Statements of Operations		Year Ended December 31, 2017				Year Ended December 31, 2016				Year Ended December 31, 2015
Total revenue		$	4,042			$	6,954			$	3,582
Gross profit			3,877				6,826				3,314
Loss from operations			(33,251)				(34,123)				(21,908)
Net loss		$	(28,372)			$	(35,489)			$	(15,003)

		December 31, 2017				December 31, 2016
Condensed Balance Sheet information ⁽¹⁾:
Current assets		$	22,716			$	36,990
Noncurrent assets			20,376				24,020
		$	43,092			$	61,010

Current liabilities		$	3,521			$	6,535
Noncurrent liabilities			6,028				12,447
Stockholders’ equity			33,543				42,028
		$	43,092			$	61,010

(1)

The condensed balance sheet information of Asterias as of December 31, 2017 and 2016, is provided for informational and comparative purposes only and was not included in BioTime’s consolidated balance sheet as of December 31, 2017 and 2016 due to the Asterias Deconsolidation on May 13, 2016.